A new mutation in Escherichia coli, designated gevAl, that results in noninducible expression of both gcv and a gcvT-kacZ gene fusion was isolated. A plasmid carrying the wild-type gcvA gene complemented the mutation and restored glycine-inducible gcv and gcvT-lacZ gene expression. These results suggest that gcvA encodes a positive-acting regulatory protein that acts in trans to increase expression of gcv.
In enteric bacteria, the conversion of serine to glycine and 5,10-methylenetetrahydrofolate occurs through the action of the enzyme serine hydroxymethyltransferase, the glyA gene product (10) . This reaction is an important contributor of one-carbon units in cell metabolism. The oxidative cleavage of glycine by the glycine cleavage (GCV) enzyme system provides a second pathway for one-carbon biosynthesis (14) . A glycine-inducible GCV enzyme system has been demonstrated in both Eschenchia coli (8, 11, 12) and Salmonella typhimurium (16) .
E. coli mutants blocked simultaneously in the GCV enzyme system and in the serine biosynthetic pathway are unable to use glycine as a serine source and require an exogenous source of serine (the GCV-phenotype). At present, six classes of mutations have been shown to result in the GCV-phenotype under the appropriate growth conditions. The first class maps at min 62.6 on the E. coli chromosome and presumably affects the gcv structural genes (12) . The second class maps at min 14.8 and disrupts the lipoic acid biosynthetic pathway (18) . The third class maps at min 2.7 and alters the lpd gene, encoding the L protein of the GCV enzyme complex (17) . The fourth class maps at min 54.8 and partially inactivates serine hydroxymethyltransferase, the glyA gene product (13) . The fifth class maps at min 95.6 and disrupts the cycA gene involved in glycine transport (2, 4) ; this class results in the GCV-phenotype because of altered glycine uptake (4a). The sixth class maps at min 20 and inactivates the lIp gene (7) . We report here a seventh locus that results in a GCV-phenotype because of the cell's inability to induce gcv expression.
Isolation of a new class ofgcv mutations. Using a penicillin counterselection previously described (1, 11, 12) , we isolated several mutants defective in the GCV enzyme pathway. One of the mutants isolated that displayed the GCVphenotype and that had a very low level of GCV enzyme activity did not map with the known structural genes encoding GCV. This strain was designated GS786 (the complete genotypes of all strains used in this study are listed in Table   1 ). A [2-14C]glycine uptake assay was performed to determine whether transport was altered in strain GS786. This strain was found to have normal transport of glycine (data not shown). Mutations in lipoic acid biosynthesis also result in a GCV-phenotype in serine auxotrophs, and growth of these mutants on glucose minimal medium (GM) containing glycine can be restored if lipoic acid is added to the medium (18) . However, the addition of exogenous lipoic acid did not restore the GCV+ phenotype in strain GS786. These results suggest that the mutation in GS786 represents a new class of gcv mutations, designated gcvAl.
Mapping the gcvAl mutation. To map the gcvAl mutation we used the comprehensive mapping kit for E. coli developed by Singer et al. (15) . An interrupted mating experiment localized gcvAl between min 59 and min 69 on the E. coli chromosome. A P1 transduction analysis was then used to map the mutation more precisely (9) . P1 clr-100 phage lysates were prepared on donor strains that carry TnlO elements at various locations in the 60-to 70-min region of the E. coli chromosome. The phage lysates were then used in transductions with the gcvAl strain GS786 as the recipient. Transductants were selected on Luria agar (9) supplemented with tetracycline (10 ,ug/ml), and tetracycline-resistant (Tcr) transductants were then scored on GM (19) To construct strain GS970, the gcvAl allele was transferred into the serA25 strain GS958 by using P1 transduction with the closely linked argA81::TnJO marker and then scoring transductants for the GCV-phenotype; the argA81::TnlO marker was finally removed by a second transduction.
b To construct strain GS973, the gcvAl allele was transferred into lysogen GS162XgcvT-lacZ by using P1 transduction with the closely linked argA81::TnlO marker and then scoring transductants for loss of activation of the XgcvT-lacZ fusion; the argA81::TnlO marker was finally removed by a second transduction.
subtracted from the 2.0 min to account for the amount of the transducing particle that is the TnlO element. The argA81::TnlO and gcvAl markers are about 0.2 min apart. We could not determine from the transduction data on which side of the argA81::TnlO marker gcvAl maps. Cloning the gcvA gene. To clone the gcvA gene, we used the miniset of specialized transducing bacteriophages of Kohara and collaborators (6) . In brief, a series of these bacteriophages containing E. coli DNA covering the deduced map position of gevA was used to infect GS970, a serA25 gcvAl strain. Infected cells were then plated on GM plates containing glycine and the appropriate supplements. Since GS970 is unable to use glycine as a serine source, only cells containing a functional gcvA gene from the X bacteriophage should be able to grow. Two such bacteriophages, 1OB6 and 9A12, complemented the GCV-phenotype and localized gcvAl to min 60.3 (Fig. 1) . DNA was prepared from phage 9A12 and digested with EcoRI, and an 11.6-kb insert fragment that spans the region common to phages 1OB6 and 9A12 was isolated. This fragment was ligated into the EcoRI site of the single-copy plasmid pGS225, a pDF41 derivative (5) containing the Tn5 kan gene (3). This new plasmid was designated pGS254.
We tested whether plasmid pGS254 could complement the GCV-phenotype by transforming strain GS970 with plasmid pGS254. Transformants were selected on Luria agar supplemented with kanamycin (20 ptg/ml). When the Knr transformants were spotted on GM plates plus glycine, the plasmid was able to complement the GCV-phenotype, allowing growth in the presence of glycine. gcvT-lacZ and GS162XgcvT-lacZ, with either plasmid pGS225 or plasmid pGS254, were then grown in GM medium without or with glycine and assayed for ,B-galactosidase and GCV enzyme activities. In the gcvA+ lysogen GS162XgcvT-lacZ/pGS225, the addition of glycine to the growth medium resulted in induction of both 3-galactosidase and GCV enzyme activities (Table 2 ). In the gcvAl lysogen GS973X gcvT-lacZIpGS225, however, the addition of glycine to the growth medium had no effect on P-galactosidase or GCV enzyme activity. Plasmid pGS254 complemented the gcvAl mutation in lysogen GS973XgcvT-lacZ, restoring both 3-galactosidase and GCV enzyme activities ( Table 2 ).
The gevAl mutation shares a number of characteristics with mutations in other genes encoding positive-acting regulatory proteins. First, the gcvAl mutation lies outside the gcv structural genes and thus acts in trans. Second, the gcvAl mutation is recessive to the wild-type allele (Table 2) . Finally, since the gcvAl mutation affects not only GCV levels but also P-galactosidase levels encoded by the XgcvTlacZ fusion, it is likely to affect synthesis of the gene products rather than their activities. These results suggest that plasmid pGS254 carries the gcvA gene and that gcvA encodes a positive-acting regulatory protein that acts in trans to activate expression of the gcv system. How this gene activates gcv expression and how gcvA itself is regulated are under study.
